Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
[See USP Controlled Room Temperature.] Distributed by Hospira, Inc., Lake Forest, IL 60045 USA LAB-0977-2.0 Revised: 08/2019
42 In the recent SURMOUNT-5 trial in adult participants with obesity but without T2DM, tirzepatide (10 mg or 15 mg) achieved greater weight loss compared with semaglutide (1.7 mg or 2.4 mg weekly dose): 20.2% (95% CI 21.4 to 19.1) versus -13.7% (95% CI 14.9 to 12.6) at week 72
Better evidence and better education are how we move it forward
Metabolic & Multi-Agonist Research Compounds explored in insulin signalling and metabolic pathways
increased intracranial pressure with papilledema (pseudotumor cerebri) usually following discontinuation of treatment
They promote steady fat metabolism and lean muscle development without overwhelming your bodys hormonal systems
US$ 22.69
US$ 27.10
US$ 21.06
US$ 24.90
US$ 23.33
